首页> 外文期刊>Autoimmunity >No evidence of association of CTLA4 polymorphisms with Addison's disease.
【24h】

No evidence of association of CTLA4 polymorphisms with Addison's disease.

机译:没有证据表明CTLA4多态性与艾迪生氏病相关。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Addison's disease (AD) is an autoimmune disorder caused by the destruction of the adrenal gland by the lymphocytes in genetically susceptible individuals. The contribution of HLA genes to the genetic risk to AD has been known for a long time; however, non-HLA genetic factors are likely to be required for the development of the disease. Several studies have associated the CD28/CTLA4 region on chromosome 2q33 with the disease in different populations. The cytotoxic T lymphocyte-associated antigen 4 (CTLA4) gene encodes a receptor involved in the control of T cell proliferation and mediates T cell apoptosis. AIM: To determine the contribution of two polymorphisms of the CTLA4 to the disease; the A/G dimorphism at position +49 in exon 1 and the (AT)n microsatellite in the 3' untranslated region of exon 3. PATIENTS: Fifty seven patients with autoimmune AD (autoimmunity for anti 21-hydroxylase was confirmed) and 111 unrelated healthy subjects from the general populations were analyzed as controls. METHODS: Restriction enzyme digestion of polymerase chain reaction (PCR) amplified genomic DNA for the A/G dimorphism and PCR followed by high-resolution electrophoresis for the (AT)n microsatellite. For disease association studies, the case-control approach was used. RESULTS: The frequency of the A allele of 49 A/G polymorphism was 65.79% in the patients compared with 72.07% in the control group. These differences were not significant. Analysis of the (AT)n polymorphism identified 19 different alleles, ranging from 262 to 308 bp in length, but no allele was significantly associated with the disease. CONCLUSIONS: Our results did not show any evidence of association of any of the CTLA4 gene polymorphisms with the disease. This might result from population-specific differences in genetic and environmental susceptibility to AD.
机译:背景:艾迪生氏病(AD)是由遗传易感人群中的淋巴细胞破坏肾上腺引起的自身免疫性疾病。 HLA基因对AD遗传风险的贡献已为人所知。但是,非HLA遗传因素可能是疾病发展所必需的。多项研究已将2q33号染色体上的CD28 / CTLA4区与不同人群的疾病相关联。细胞毒性T淋巴细胞相关抗原4(CTLA4)基因编码参与控制T细胞增殖并介导T细胞凋亡的受体。目的:确定CTLA4的两个多态性对该疾病的贡献;外显子1的+49位置的A / G二态性和外显子3的3'非翻译区域的(AT)n微卫星位。患者:57例自身免疫性AD患者(已确认抗21-羟化酶的自身免疫性),与111例无关分析来自一般人群的健康受试者作为对照。方法:限制性酶消化聚合酶链反应(PCR)扩增的基因组DNA,用于A / G二态性和PCR,然后对(AT)n微卫星进行高分辨率电泳。对于疾病关联研究,使用病例对照方法。结果:患者49 A / G多态性的A等位基因频率为65.79%,而对照组为72.07%。这些差异并不明显。对(AT)n多态性的分析确定了19个不同的等位基因,其长度在262至308 bp之间,但没有等位基因与该疾病显着相关。结论:我们的结果未显示任何CTLA4基因多态性与疾病相关的证据。这可能是由于人群对AD的遗传和环境敏感性差异所致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号